Article Text
PostScript
Correspondence
Letter to the editors
Statistics from Altmetric.com
We read with interest your ‘Highlights from this Issue’ in the November issue of Thorax.1 We noticed that you had a fresh comment on Global Initiative for Obstructive Lung Diseases (GOLD) not recommending macrolides to prevent exacerbations of chronic obstructive pulmonary disease (COPD).
We also noted that you hinted that it was probably too cheap for GOLD—suggesting that we were in the pockets of ‘big pharma’. We find the remark hurtful and wrong. GOLD does …
Linked Articles
- PostScript